Abstract:CONTEXT: Self-emulsifying drug delivery systems (SEDDS) are among most promising tools for improving oral peptide bioavailability.OBJECTIVE: In this study, in vitro protective effect of SEDDS containing desmopressin against presystemic inactivation by glutathione and α-chymotrypsin was evaluated.MATERIALS AND METHODS: The partitioning coefficient (log P) of desmopressin was increased via hydrophobic ion pairing using anionic surfactants. Solubility studies were performed to select the appropriate solvents for SEDDS preparation. Subsequently, droplet size and emulsification properties of 22 SEDDS formulations were evaluated. Moreover, the peptide-surfactant complex was dissolved in two chosen SEDDS formulations. Finally, SEDDS containing desmopressin were characterized regarding lipase stability, toxicity, and in vitro protective effect toward glutathione and α-chymotrypsin.RESULTS: Desmopressin log P was increased from initial -6.13 to 0.33 using sodium docusate. The resulting desmopressin docusate complex (DES/AOT) was incorporated in two different SEDDS formulations, containing Capmul 907 P as main solvent. DES/AOT-SEDDS-F4 (containing 0.07% w/w DES/AOT) was composed of 50% Capmul 907P, 40% Cremophor RH40, and 10% Transcutol. The comparatively more hydrophilic formulation DES/AOT-SEDDS-F15 (containing 0.25% w/w DES/AOT) consisted of 20% Capmul 907P, 40% Acconon MC8-2, and 40% Tween 20. Both formulations were stable toward digestion by lipase and protected desmopressin toward α-chymotrypsin degradation. Moreover, DES/AOT-SEDDS-F4 also protected the peptide from thiol/disulfide exchange reactions with glutathione and was not cytotoxic at a concentration of 0.375% (w/w).CONCLUSION: DES/AOT-SEDDS-F4 protected desmopressin from in vitro glutathione and α-chymotrypsin degradation. DES/AOT-SEDDS-F4 was metabolically stable and nontoxic. Therefore, it could be considered as a potential delivery system for oral desmopressin administration.

Preparation and Quality Evaluation of Dially Trisuifide Self-Microemulsifying Drug Delivery System

The Study on Preparation and Quality of DATS Microemulsion

Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin.

Study on Nimodipine Self-microemulsifying Drug Delivery System

Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin

Design of self-microemulsifying drug delivery systems using a high-throughput formulation screening system

An oil-free microemulsion for intravenous delivery of diallyl trisulfide: formulation and evaluation.

Development and in vitro evaluation of an oral SEDDS for desmopressin

Formulation and Stability Studies on Paclitaxel Self-microemulsifying Drug Delivery System

Preparation and in Vitro Evaluation of Self-Microemulsifying Drug Delivery System with Alkaloids from Corydalis Saxicola Bunting

Design, Characterization, and Evaluation of Diosmetin-Loaded Solid Self-microemulsifying Drug Delivery System Prepared by Electrospray for Improved Bioavailability

Development of solidified self-microemulsifying drug delivery systems containing l-tetrahydropalmatine: Design of experiment approach and bioavailability comparison

Preparation and evaluation of self-microemulsifying drug delivery system of baicalein

Formulation of self-microemulsifying drug delivery system (SMEDDS) of ibuprofen for oral delivery

Resveratrol Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and Optimization

Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation

Preparation and Characterisation of A Soy Lecithin-Based Self-Microemulsifying Drug Delivery System of Resveratrol

Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead

Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier

Development of self-microemulsifying drug delivery system of mebendazole by spray drying technology: Characterization, in vitro and in vivo evaluation